 Gregory Forlenza
Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Infusion Systems | 78 | 2025 | 363 | 16.420 |
Why?
| | Diabetes Mellitus, Type 1 | 102 | 2025 | 3630 | 12.150 |
Why?
| | Blood Glucose Self-Monitoring | 70 | 2025 | 601 | 8.920 |
Why?
| | Pancreas, Artificial | 26 | 2022 | 70 | 8.760 |
Why?
| | Blood Glucose | 93 | 2025 | 2103 | 8.550 |
Why?
| | Insulin | 80 | 2025 | 2330 | 8.190 |
Why?
| | Hypoglycemic Agents | 77 | 2025 | 1221 | 8.040 |
Why?
| | Hypoglycemia | 32 | 2024 | 427 | 5.820 |
Why?
| | Hyperglycemia | 15 | 2023 | 327 | 3.400 |
Why?
| | Hematopoietic Stem Cell Transplantation | 5 | 2022 | 577 | 2.180 |
Why?
| | Islets of Langerhans Transplantation | 5 | 2024 | 63 | 1.740 |
Why?
| | Monitoring, Ambulatory | 5 | 2018 | 83 | 1.720 |
Why?
| | Diabetes Mellitus | 8 | 2025 | 1003 | 1.590 |
Why?
| | Pancreatectomy | 5 | 2024 | 242 | 1.520 |
Why?
| | Child | 61 | 2025 | 20962 | 1.490 |
Why?
| | Algorithms | 17 | 2025 | 1617 | 1.470 |
Why?
| | Adolescent | 60 | 2025 | 20451 | 1.430 |
Why?
| | Insulin-Secreting Cells | 3 | 2023 | 367 | 1.350 |
Why?
| | Humans | 130 | 2025 | 129847 | 1.330 |
Why?
| | Pancreatitis, Chronic | 4 | 2024 | 51 | 1.250 |
Why?
| | Biomedical Technology | 2 | 2019 | 42 | 1.180 |
Why?
| | Young Adult | 34 | 2024 | 12467 | 1.060 |
Why?
| | Verapamil | 2 | 2023 | 41 | 1.050 |
Why?
| | Patient Education as Topic | 3 | 2021 | 743 | 1.040 |
Why?
| | Adult | 50 | 2025 | 35634 | 0.880 |
Why?
| | Telemedicine | 3 | 2022 | 792 | 0.860 |
Why?
| | Technology | 5 | 2023 | 87 | 0.840 |
Why?
| | Male | 57 | 2025 | 63759 | 0.820 |
Why?
| | Calcium Channel Blockers | 1 | 2023 | 161 | 0.780 |
Why?
| | Child, Preschool | 18 | 2024 | 10522 | 0.740 |
Why?
| | Female | 54 | 2025 | 68829 | 0.740 |
Why?
| | Lymphoma | 1 | 2023 | 198 | 0.740 |
Why?
| | Glucose | 9 | 2024 | 1003 | 0.700 |
Why?
| | Patient Dropouts | 1 | 2020 | 64 | 0.640 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 279 | 0.640 |
Why?
| | Patient Satisfaction | 3 | 2024 | 639 | 0.620 |
Why?
| | Personal Satisfaction | 1 | 2020 | 204 | 0.590 |
Why?
| | Diabetic Ketoacidosis | 5 | 2024 | 197 | 0.590 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2023 | 2444 | 0.590 |
Why?
| | Transplantation Conditioning | 1 | 2019 | 166 | 0.560 |
Why?
| | Eczema | 1 | 2018 | 67 | 0.560 |
Why?
| | Treatment Outcome | 17 | 2024 | 10241 | 0.550 |
Why?
| | Betacoronavirus | 1 | 2020 | 252 | 0.550 |
Why?
| | Diabetic Retinopathy | 2 | 2024 | 179 | 0.530 |
Why?
| | Self-Management | 1 | 2019 | 163 | 0.530 |
Why?
| | Machine Learning | 2 | 2025 | 441 | 0.520 |
Why?
| | Diffusion of Innovation | 1 | 2017 | 97 | 0.520 |
Why?
| | Artificial Intelligence | 1 | 2019 | 245 | 0.500 |
Why?
| | Quality of Life | 4 | 2024 | 2695 | 0.500 |
Why?
| | Insulin, Regular, Human | 7 | 2023 | 43 | 0.480 |
Why?
| | Endocrine Glands | 1 | 2015 | 15 | 0.480 |
Why?
| | Transplantation, Autologous | 4 | 2024 | 213 | 0.480 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.470 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.470 |
Why?
| | Endocrine System Diseases | 1 | 2015 | 33 | 0.470 |
Why?
| | Insulin Lispro | 3 | 2024 | 39 | 0.470 |
Why?
| | Fanconi Anemia | 1 | 2013 | 10 | 0.440 |
Why?
| | Dwarfism | 1 | 2013 | 15 | 0.430 |
Why?
| | Retrospective Studies | 12 | 2024 | 14553 | 0.430 |
Why?
| | Growth Hormone | 1 | 2013 | 100 | 0.420 |
Why?
| | Aged | 19 | 2024 | 22107 | 0.420 |
Why?
| | Skin | 1 | 2018 | 725 | 0.420 |
Why?
| | Suicide | 1 | 2020 | 616 | 0.400 |
Why?
| | Blindness | 1 | 2012 | 38 | 0.390 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 778 | 0.380 |
Why?
| | Cross-Over Studies | 6 | 2024 | 521 | 0.380 |
Why?
| | Middle Aged | 22 | 2025 | 31177 | 0.370 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 486 | 0.370 |
Why?
| | Pandemics | 1 | 2020 | 1500 | 0.370 |
Why?
| | Exercise | 8 | 2025 | 1934 | 0.370 |
Why?
| | Biosensing Techniques | 2 | 2025 | 118 | 0.360 |
Why?
| | Angiogenesis Inhibitors | 1 | 2012 | 218 | 0.360 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2016 | 1368 | 0.350 |
Why?
| | Calibration | 3 | 2020 | 140 | 0.350 |
Why?
| | United States | 13 | 2025 | 13913 | 0.350 |
Why?
| | Lingual Frenum | 1 | 2010 | 2 | 0.340 |
Why?
| | Tongue Diseases | 1 | 2010 | 9 | 0.340 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2008 | 0.340 |
Why?
| | Failure to Thrive | 1 | 2010 | 29 | 0.340 |
Why?
| | Epidemics | 1 | 2011 | 82 | 0.340 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 528 | 0.330 |
Why?
| | Medicaid | 3 | 2022 | 433 | 0.330 |
Why?
| | Models, Biological | 1 | 2016 | 1724 | 0.320 |
Why?
| | Infant | 6 | 2023 | 9018 | 0.310 |
Why?
| | Double-Blind Method | 4 | 2023 | 1877 | 0.310 |
Why?
| | Follow-Up Studies | 5 | 2021 | 4896 | 0.290 |
Why?
| | Skiing | 2 | 2019 | 44 | 0.280 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 2 | 2017 | 26 | 0.270 |
Why?
| | Inventions | 2 | 2018 | 18 | 0.270 |
Why?
| | Caregivers | 2 | 2024 | 809 | 0.260 |
Why?
| | Endocrinology | 2 | 2018 | 74 | 0.250 |
Why?
| | Postoperative Complications | 2 | 2015 | 2481 | 0.250 |
Why?
| | Outpatients | 2 | 2021 | 375 | 0.250 |
Why?
| | Insulin Aspart | 2 | 2022 | 26 | 0.250 |
Why?
| | Meals | 4 | 2024 | 119 | 0.240 |
Why?
| | Overweight | 2 | 2023 | 531 | 0.240 |
Why?
| | Risk Factors | 5 | 2020 | 9801 | 0.240 |
Why?
| | C-Peptide | 2 | 2023 | 163 | 0.240 |
Why?
| | Injections, Subcutaneous | 3 | 2020 | 146 | 0.240 |
Why?
| | Body Height | 2 | 2017 | 192 | 0.230 |
Why?
| | Mutation | 1 | 2015 | 3706 | 0.220 |
Why?
| | Feasibility Studies | 5 | 2018 | 870 | 0.210 |
Why?
| | Equipment Failure | 3 | 2018 | 106 | 0.200 |
Why?
| | Insulins | 1 | 2023 | 37 | 0.200 |
Why?
| | Eligibility Determination | 1 | 2022 | 63 | 0.200 |
Why?
| | Awareness | 1 | 2023 | 99 | 0.190 |
Why?
| | Pediatrics | 2 | 2020 | 1074 | 0.180 |
Why?
| | Automobile Driving | 1 | 2023 | 140 | 0.180 |
Why?
| | Prospective Studies | 6 | 2023 | 7158 | 0.180 |
Why?
| | Infusion Pumps, Implantable | 1 | 2020 | 23 | 0.170 |
Why?
| | Smartphone | 2 | 2019 | 87 | 0.170 |
Why?
| | Computer Systems | 1 | 2020 | 44 | 0.170 |
Why?
| | Medicare | 2 | 2022 | 719 | 0.170 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2019 | 62 | 0.160 |
Why?
| | Sports | 2 | 2019 | 225 | 0.160 |
Why?
| | Fatal Outcome | 1 | 2020 | 300 | 0.160 |
Why?
| | Reproducibility of Results | 4 | 2024 | 3089 | 0.150 |
Why?
| | Prevalence | 3 | 2023 | 2564 | 0.150 |
Why?
| | Software | 2 | 2021 | 608 | 0.150 |
Why?
| | Clinical Alarms | 1 | 2017 | 10 | 0.140 |
Why?
| | Night Terrors | 1 | 2017 | 1 | 0.140 |
Why?
| | Insulinoma | 1 | 2017 | 30 | 0.140 |
Why?
| | Device Approval | 1 | 2017 | 21 | 0.140 |
Why?
| | Survival Analysis | 1 | 2020 | 1271 | 0.140 |
Why?
| | Diet, Diabetic | 1 | 2017 | 35 | 0.140 |
Why?
| | Voluntary Health Agencies | 1 | 2016 | 5 | 0.130 |
Why?
| | Adrenal Hyperplasia, Congenital | 1 | 2017 | 37 | 0.130 |
Why?
| | Program Evaluation | 1 | 2021 | 878 | 0.130 |
Why?
| | Obesity | 3 | 2023 | 2885 | 0.130 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 205 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 1 | 2017 | 158 | 0.120 |
Why?
| | Statistics as Topic | 1 | 2016 | 306 | 0.120 |
Why?
| | Abdominal Pain | 1 | 2017 | 143 | 0.120 |
Why?
| | Drug Overdose | 1 | 2020 | 326 | 0.120 |
Why?
| | Health Services Accessibility | 1 | 2022 | 903 | 0.120 |
Why?
| | Hypophosphatasia | 1 | 2015 | 3 | 0.120 |
Why?
| | Age Factors | 3 | 2018 | 3161 | 0.120 |
Why?
| | Drug Delivery Systems | 1 | 2018 | 337 | 0.120 |
Why?
| | Pilot Projects | 2 | 2020 | 1597 | 0.120 |
Why?
| | Alkaline Phosphatase | 1 | 2015 | 147 | 0.110 |
Why?
| | Autografts | 1 | 2014 | 42 | 0.110 |
Why?
| | Consensus | 3 | 2023 | 622 | 0.110 |
Why?
| | Europe | 2 | 2025 | 363 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2016 | 304 | 0.110 |
Why?
| | Choristoma | 1 | 2013 | 21 | 0.110 |
Why?
| | Glucose Clamp Technique | 1 | 2014 | 194 | 0.110 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2013 | 34 | 0.110 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 402 | 0.100 |
Why?
| | Postoperative Period | 1 | 2014 | 330 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5437 | 0.100 |
Why?
| | Allografts | 1 | 2013 | 137 | 0.100 |
Why?
| | Pituitary Gland | 1 | 2013 | 148 | 0.100 |
Why?
| | Clinical Protocols | 1 | 2014 | 254 | 0.100 |
Why?
| | Patient Compliance | 1 | 2017 | 568 | 0.100 |
Why?
| | Graft Survival | 1 | 2015 | 514 | 0.100 |
Why?
| | Bionics | 2 | 2022 | 12 | 0.100 |
Why?
| | Quality Improvement | 1 | 2021 | 1112 | 0.100 |
Why?
| | Genetic Testing | 1 | 2015 | 422 | 0.100 |
Why?
| | Adipose Tissue | 1 | 2016 | 594 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2017 | 507 | 0.100 |
Why?
| | Pituitary Neoplasms | 1 | 2013 | 180 | 0.100 |
Why?
| | Body Mass Index | 2 | 2017 | 2274 | 0.090 |
Why?
| | Graft Rejection | 1 | 2015 | 598 | 0.090 |
Why?
| | Prognosis | 2 | 2020 | 3773 | 0.090 |
Why?
| | Age of Onset | 1 | 2012 | 494 | 0.090 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2724 | 0.090 |
Why?
| | Biomedical Research | 1 | 2016 | 640 | 0.090 |
Why?
| | Critical Illness | 1 | 2016 | 759 | 0.080 |
Why?
| | Global Health | 1 | 2012 | 329 | 0.080 |
Why?
| | Activities of Daily Living | 3 | 2017 | 384 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 879 | 0.080 |
Why?
| | Electronic Health Records | 1 | 2016 | 979 | 0.080 |
Why?
| | Biomarkers | 1 | 2020 | 3971 | 0.080 |
Why?
| | Guideline Adherence | 1 | 2012 | 527 | 0.070 |
Why?
| | Hospitalization | 3 | 2024 | 2079 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2015 | 3384 | 0.070 |
Why?
| | Equipment Design | 2 | 2019 | 514 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2019 | 5772 | 0.070 |
Why?
| | Cold Temperature | 2 | 2019 | 155 | 0.070 |
Why?
| | Weight Gain | 1 | 2010 | 510 | 0.060 |
Why?
| | Breast Feeding | 1 | 2010 | 424 | 0.060 |
Why?
| | Incidence | 1 | 2012 | 2646 | 0.060 |
Why?
| | Seasons | 2 | 2019 | 493 | 0.060 |
Why?
| | Mass Screening | 1 | 2012 | 1192 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1514 | 0.060 |
Why?
| | Risk | 2 | 2017 | 860 | 0.060 |
Why?
| | Child Abuse | 1 | 2010 | 513 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1201 | 0.050 |
Why?
| | Diet | 1 | 2011 | 1212 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2025 | 374 | 0.050 |
Why?
| | Insulin Resistance | 1 | 2011 | 1168 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 1 | 2023 | 106 | 0.050 |
Why?
| | Standard of Care | 1 | 2023 | 71 | 0.050 |
Why?
| | Reference Standards | 1 | 2021 | 176 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2022 | 220 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2020 | 68 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2023 | 569 | 0.040 |
Why?
| | Pancreas | 1 | 2022 | 305 | 0.040 |
Why?
| | Social Conditions | 1 | 2019 | 11 | 0.040 |
Why?
| | Inpatients | 1 | 2024 | 477 | 0.040 |
Why?
| | Disease Management | 1 | 2023 | 592 | 0.040 |
Why?
| | Equipment and Supplies | 1 | 2018 | 41 | 0.040 |
Why?
| | International Cooperation | 1 | 2018 | 177 | 0.040 |
Why?
| | Time Factors | 2 | 2018 | 6550 | 0.040 |
Why?
| | Postprandial Period | 1 | 2018 | 105 | 0.040 |
Why?
| | Virginia | 1 | 2017 | 60 | 0.040 |
Why?
| | Snacks | 1 | 2017 | 19 | 0.030 |
Why?
| | Colorado | 2 | 2017 | 4410 | 0.030 |
Why?
| | Mobile Applications | 1 | 2020 | 166 | 0.030 |
Why?
| | Ohio | 1 | 2017 | 152 | 0.030 |
Why?
| | Reference Values | 1 | 2018 | 796 | 0.030 |
Why?
| | Minnesota | 1 | 2017 | 149 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2017 | 104 | 0.030 |
Why?
| | Accelerometry | 1 | 2017 | 93 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2022 | 580 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2017 | 271 | 0.030 |
Why?
| | Food Preferences | 1 | 2017 | 116 | 0.030 |
Why?
| | Hypertrophy | 1 | 2016 | 125 | 0.030 |
Why?
| | Materials Testing | 1 | 2017 | 349 | 0.030 |
Why?
| | Child Behavior | 1 | 2017 | 236 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 759 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 510 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2018 | 626 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2022 | 7066 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1274 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2739 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 5444 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3397 | 0.010 |
Why?
|
|
Forlenza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|